Search for a command to run...
Agios Pharmaceuticals, Inc.
Biotechnology
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Aug 20, 2026 |  Gilbert CisnerosD | Stock | Buy |
| $1,001 - $15,000 |
| $33.63 |
| $33.07 |
| -1.7% |
| -1.8% |
Mar 3, 2026 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $28.48 | $35.20 | +23.6% | +26.9% |
Dec 11, 2025 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $27.46 | $28.41 | +3.5% | +2.5% |
Apr 17, 2025 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $27.66 | $29.18 | +5.5% | -7.4% |
Jan 29, 2025 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $33.73 | $35.54 | +5.4% | +6.6% |
Agios Pharmaceuticals: Indication Stacking Is Creating A Commercial Flywheel
Servier’s $2.5B cancer bet underlines a quick oncology growth strategy
Agios Pharmaceuticals: Worthy Of Accumulation
How The Agios Pharmaceuticals (AGIO) Story Is Shifting After Aqvesme Approval And New Targets
Agios Pharmaceuticals Teases 2026 Catalysts as PYRUKYND Thalassemia Launch Gains Early Traction